Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity

por Zhang, Yue, Hochster, Howard, Stein, Stacey, Lacy, Jill
Publicado 2015

Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis

por Yoshino, Takayuki, Taieb, Julien, Kuboki, Yasutoshi, Pfeiffer, Per, Kumar, Amit, Hochster, Howard S.
Publicado 2023

A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease

por Stahl, John M, Walther, Zenta, Chang, Bryan W, Hochster, Howard S, Johung, Kimberly L
Publicado 2017

A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer

por Eng, Cathy, Fakih, Marwan, Amin, Manik, Morris, Van, Hochster, Howard S., Boland, Patrick M., Uronis, Hope
Publicado 2020

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases

por Dendy, Meaghan S., Ludwig, Johannes M., Kokabi, Nima, Stein, Stacey M., Lacy, Jill, Hochster, Howard S., Kim, Hyun S.
Publicado 2018

Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial

por Ghidini, Michele, Hochster, Howard, Doi, Toshihiko, Van Cutsem, Eric, Makris, Lukas, Takahashi, Osamu, Benhadji, Karim A., Mansoor, Wasat
Publicado 2023

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study

por Kasi, Pashtoon M., Kotani, Daisuke, Cecchini, Michael, Shitara, Kohei, Ohtsu, Atsushi, Ramanathan, Ramesh K., Hochster, Howard S., Grothey, Axel, Yoshino, Takayuki
Publicado 2016

Young-Onset Colon Cancer and Recurrence Risk by Gene Expression

por Chang, George J, You, Y Nancy Y, Russell, Christy A, Tierno, Marni B, Turner, Michelle, Bennett, John P, Lau, Anna, Hochster, Howard S
Publicado 2020

Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up

por Rosenberg, Ari Joseph, Rademaker, Alfred, Hochster, Howard S., Ryan, Theresa, Hensing, Thomas, Shankaran, Veena, Baddi, Lisa, Mahalingam, Devalingam, Mulcahy, Mary F., Benson, Al B.
Publicado 2019

A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)

por Scott, Aaron J., Basu Mallick, Atrayee, Dotan, Efrat, Cohen, Steven J., Gold, Philip J., Hochster, Howard S., Subramaniam, Somasundaram, Barzi, Afsaneh, Watts, George S., Blatchford, Patrick J., Messersmith, Wells A.
Publicado 2022

Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A ra...

por Chiorean, E. Gabriela, Picozzi, Vincent, Li, Chung‐Pin, Peeters, Marc, Maurel, Joan, Singh, Jaswinder, Golan, Talia, Blanc, Jean‐Frédéric, Chapman, Sonya C., Hussain, Anwar M., Johnston, Erica L., Hochster, Howard S.
Publicado 2023

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer

por Stein, Stacey M, James, Edward S, Deng, Yanhong, Cong, Xiangyu, Kortmansky, Jeremy S, Li, Jia, Staugaard, Carol, Indukala, Doddamane, Boustani, Ann Marie, Patel, Vatsal, Cha, Charles H, Salem, Ronald R, Chang, Bryan, Hochster, Howard S, Lacy, Jill
Publicado 2016

Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research

por Kumar, Ritesh, Kim, Jongmyung, Deek, Matthew P., Eskander, Mariam F., Gulhati, Prateek, In, Haejin, Kennedy, Timothy, Shah, Mihir M., Grandhi, Miral S., Berim, Lyudmyla, Spencer, Kristen R., Langan, Russell C., Hochster, Howard S., Boland, Patrick M., Jabbour, Salma K.
Publicado 2023

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

por Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.
Publicado 2021

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

por Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.
Publicado 2022

Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes

por Sayan, Mutlay, Yegya-Raman, Nikhil, Greco, Stephanie H., Gui, Bin, Zhang, Andrew, Chundury, Anupama, Grandhi, Miral S., Hochster, Howard S., Kennedy, Timothy J., Langan, Russell C., Malhotra, Usha, Rustgi, Vinod K., Shah, Mihir M., Spencer, Kristen R., Carpizo, Darren R., Nosher, John L., Jabbour, Salma K.
Publicado 2019

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405

por Guercio, Brendan J, Zhang, Sui, Venook, Alan P, Ou, Fang-Shu, Niedzwiecki, Donna, Lenz, Heinz-Josef, Innocenti, Federico, Mullen, Brian C, O’Neil, Bert H, Shaw, James E, Polite, Blase N, Hochster, Howard S, Atkins, James N, Goldberg, Richard M, Brown, Justin C, O’Reilly, Eileen M, Mayer, Robert J, Blanke, Charles D, Fuchs, Charles S, Meyerhardt, Jeffrey A
Publicado 2020

Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial

por Van Blarigan, Erin L., Zhang, Sui, Ou, Fang-Shu, Venlo, Alan, Ng, Kimmie, Atreya, Chloe, Van Loon, Katherine, Niedzwiecki, Donna, Giovannucci, Edward, Wolfe, Eric G., Lenz, Heinz-Josef, Innocenti, Federico, O’Neil, Bert H., Shaw, James E., Polite, Blase N., Hochster, Howard S., Atkins, James N., Goldberg, Richard M., Mayer, Robert J., Blanke, Charles D., O’Reilly, Eileen M., Fuchs, Charles S., Meyerhardt, Jeffrey A.
Publicado 2020

Development of a novel, pan-variant aerosol intervention for COVID-19

por Shoemaker, Robert H., Panettieri, Reynold A., Libutti, Steven K., Hochster, Howard S., Watts, Norman R., Wingfield, Paul T., Starkl, Philipp, Pimenov, Lisabeth, Gawish, Riem, Hladik, Anastasiya, Knapp, Sylvia, Boring, Daniel, White, Jonathan M., Lawrence, Quentin, Boone, Jeremy, Marshall, Jason D., Matthews, Rebecca L., Cholewa, Brian D., Richig, Jeffrey W., Chen, Ben T., McCormick, David L., Gugensberger, Romana, Höller, Sonja, Penninger, Josef M., Wirnsberger, Gerald
Publicado 2021

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer

por Shoemaker, Robert H., Panettieri, Reynold A., Libutti, Steven K., Hochster, Howard S., Watts, Norman R., Wingfield, Paul T., Starkl, Philipp, Pimenov, Lisabeth, Gawish, Riem, Hladik, Anastasiya, Knapp, Sylvia, Boring, Daniel, White, Jonathan M., Lawrence, Quentin, Boone, Jeremy, Marshall, Jason D., Matthews, Rebecca L., Cholewa, Brian D., Richig, Jeffrey W., Chen, Ben T., McCormick, David L., Gugensberger, Romana, Höller, Sonja, Penninger, Josef M., Wirnsberger, Gerald
Publicado 2022